カテゴリー： QYResearch, 世界

ヒトDNAワクチンの世界市場：規模・現状・予測

◆英語タイトル：Global Human DNA Vaccines Market Size, Status and Forecast 2019-2025
◆商品コード：DATA909X18554
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月25日（※2024年版があります。お問い合わせください）
◆ページ数：96
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,900 ⇒換算￥577,200	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,850 ⇒換算￥865,800	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,800 ⇒換算￥1,154,400	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※当調査レポートでは、ヒトDNAワクチンの世界市場について調査・分析し、ヒトDNAワクチンの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（組換えタンパク質ワクチン、遺伝子ベースワクチン）、用途別（インフルエンザ、ヒトパピローマウイルス、HIV）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界のヒトDNAワクチン市場動向
・主要企業別マーケットシェア
・ヒトDNAワクチンの種類別市場規模2014-2019
（組換えタンパク質ワクチン、遺伝子ベースワクチン）
・ヒトDNAワクチンの用途別市場規模2014-2019
（インフルエンザ、ヒトパピローマウイルス、HIV）
・ヒトDNAワクチンの北米市場：主要企業・種類別/用途別市場規模
・ヒトDNAワクチンのヨーロッパ市場：主要企業・種類別/用途別市場規模
・ヒトDNAワクチンの中国市場：主要企業・種類別/用途別市場規模
・ヒトDNAワクチンの日本国内市場：主要企業・種類別/用途別市場規模
・ヒトDNAワクチンの東南アジア市場：主要企業・種類別/用途別市場規模
・ヒトDNAワクチンのインド市場：主要企業・種類別/用途別市場規模
・ヒトDNAワクチンの中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Merck、GSK、Sanofi、Zoties、Elanco、Boehringer-Ingelheim、Indian Immunologicals、Plumbline Life Sciences）
・ヒトDNAワクチンの市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

【レポートの概要】

DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunogenicity when compared to protein vaccines. A wide variety of strategies have been developed to optimize DNA vaccine immunogenicity, including codon optimization, genetic adjuvants, electroporation and sophisticated prime-boost regimens, with each of these methods having its advantages and limitations. Whilst each of these methods has contributed to incremental improvements in DNA vaccine efficacy, more is still needed if human DNA vaccines are to succeed commercially. In 2018, the global Human DNA Vaccines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Human DNA Vaccines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human DNA Vaccines development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences

Market segment by Type, the product can be split into
Recombinant Protein Vaccine
Gene-Based Vaccine

Market segment by Application, split into
Influenza
Human Papillomavirus
HIV

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Human DNA Vaccines status, future forecast, growth opportunity, key market and key players.
To present the Human DNA Vaccines development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Human DNA Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Human DNA Vaccines Market Size Growth Rate by Type (2014-2025)
1.4.2 Recombinant Protein Vaccine
1.4.3 Gene-Based Vaccine
1.5 Market by Application
1.5.1 Global Human DNA Vaccines Market Share by Application (2019-2025)
1.5.2 Influenza
1.5.3 Human Papillomavirus
1.5.4 HIV
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Human DNA Vaccines Market Size
2.2 Human DNA Vaccines Growth Trends by Regions
2.2.1 Human DNA Vaccines Market Size by Regions (2019-2025)
2.2.2 Human DNA Vaccines Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Human DNA Vaccines Market Size by by Players
3.1.1 Global Human DNA Vaccines Revenue by by Players (2014-2019)
3.1.2 Global Human DNA Vaccines Revenue Market Share by by Players (2014-2019)
3.1.3 Global Human DNA Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Human DNA Vaccines Key Players Head office and Area Served
3.3 Key Players Human DNA Vaccines Product/Solution/Service
3.4 Date of Enter into Human DNA Vaccines Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Human DNA Vaccines Market Size by Type (2014-2019)
4.2 Global Human DNA Vaccines Market Size by Application (2014-2019)

5 North America
5.1 North America Human DNA Vaccines Market Size (2014-2019)
5.2 Human DNA Vaccines Key Players in North America
5.3 North America Human DNA Vaccines Market Size by Type
5.4 North America Human DNA Vaccines Market Size by Application

6 Europe
6.1 Europe Human DNA Vaccines Market Size (2014-2019)
6.2 Human DNA Vaccines Key Players in Europe
6.3 Europe Human DNA Vaccines Market Size by Type
6.4 Europe Human DNA Vaccines Market Size by Application

7 China
7.1 China Human DNA Vaccines Market Size (2014-2019)
7.2 Human DNA Vaccines Key Players in China
7.3 China Human DNA Vaccines Market Size by Type
7.4 China Human DNA Vaccines Market Size by Application

8 Japan
8.1 Japan Human DNA Vaccines Market Size (2014-2019)
8.2 Human DNA Vaccines Key Players in Japan
8.3 Japan Human DNA Vaccines Market Size by Type
8.4 Japan Human DNA Vaccines Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Human DNA Vaccines Market Size (2014-2019)
9.2 Human DNA Vaccines Key Players in Southeast Asia
9.3 Southeast Asia Human DNA Vaccines Market Size by Type
9.4 Southeast Asia Human DNA Vaccines Market Size by Application

10 India
10.1 India Human DNA Vaccines Market Size (2014-2019)
10.2 Human DNA Vaccines Key Players in India
10.3 India Human DNA Vaccines Market Size by Type
10.4 India Human DNA Vaccines Market Size by Application

11 Central & South America
11.1 Central & South America Human DNA Vaccines Market Size (2014-2019)
11.2 Human DNA Vaccines Key Players in Central & South America
11.3 Central & South America Human DNA Vaccines Market Size by Type
11.4 Central & South America Human DNA Vaccines Market Size by Application

12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Human DNA Vaccines Introduction
12.1.4 Merck Revenue in Human DNA Vaccines Business (2014-2019))
12.1.5 Merck Recent Development
12.2 GSK
12.2.1 GSK Company Details
12.2.2 Company Description and Business Overview
12.2.3 Human DNA Vaccines Introduction
12.2.4 GSK Revenue in Human DNA Vaccines Business (2014-2019)
12.2.5 GSK Recent Development
12.3 Sanofi
12.3.1 Sanofi Company Details
12.3.2 Company Description and Business Overview
12.3.3 Human DNA Vaccines Introduction
12.3.4 Sanofi Revenue in Human DNA Vaccines Business (2014-2019)
12.3.5 Sanofi Recent Development
12.4 Zoties
12.4.1 Zoties Company Details
12.4.2 Company Description and Business Overview
12.4.3 Human DNA Vaccines Introduction
12.4.4 Zoties Revenue in Human DNA Vaccines Business (2014-2019)
12.4.5 Zoties Recent Development
12.5 Elanco
12.5.1 Elanco Company Details
12.5.2 Company Description and Business Overview
12.5.3 Human DNA Vaccines Introduction
12.5.4 Elanco Revenue in Human DNA Vaccines Business (2014-2019)
12.5.5 Elanco Recent Development
12.6 Boehringer-Ingelheim
12.6.1 Boehringer-Ingelheim Company Details
12.6.2 Company Description and Business Overview
12.6.3 Human DNA Vaccines Introduction
12.6.4 Boehringer-Ingelheim Revenue in Human DNA Vaccines Business (2014-2019)
12.6.5 Boehringer-Ingelheim Recent Development
12.7 Indian Immunologicals
12.7.1 Indian Immunologicals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Human DNA Vaccines Introduction
12.7.4 Indian Immunologicals Revenue in Human DNA Vaccines Business (2014-2019)
12.7.5 Indian Immunologicals Recent Development
12.8 Plumbline Life Sciences
12.8.1 Plumbline Life Sciences Company Details
12.8.2 Company Description and Business Overview
12.8.3 Human DNA Vaccines Introduction
12.8.4 Plumbline Life Sciences Revenue in Human DNA Vaccines Business (2014-2019)
12.8.5 Plumbline Life Sciences Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Human DNA Vaccines Key Market Segments
Table Key Players Human DNA Vaccines Covered
Table Global Human DNA Vaccines Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Recombinant Protein Vaccine Figures
Table Key Players of Recombinant Protein Vaccine
Figuer Gene-Based Vaccine Figures
Table Key Players of Gene-Based Vaccine
Table Global Human DNA Vaccines Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Human DNA Vaccines Market Share by Application in 2018 & 2025
Figure Influenza Case Studies
Figure Human Papillomavirus Case Studies
Figure HIV Case Studies
Figure Human DNA Vaccines Report Years Considered
Figure Global Human DNA Vaccines Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Human DNA Vaccines Market Size by Regions 2019-2025 (Million US$)
Table Global Human DNA Vaccines Market Size by Regions 2019-2025 (Million US$)
Table Global Human DNA Vaccines Market Share by Regions 2014-2019
Figure Global Human DNA Vaccines Market Share by Regions 2014-2019
Figure Global Human DNA Vaccines Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Human DNA Vaccines Revenue by by Players (2014-2019) (Million US$)
Table Global Human DNA Vaccines Market Share by by Players (2014-2019)
Figure Global Human DNA Vaccines Market Share by by Players in 2018
Table Global Human DNA Vaccines by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Human DNA Vaccines Product/Solution/Service
Table Date of Enter into Human DNA Vaccines Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Human DNA Vaccines Market Size by Type (2014-2019) (Million US$)
Table Global Human DNA Vaccines Market Size Share by Type (2014-2019)
Figure Global Human DNA Vaccines Market Size Market Share by Type (2014-2019)
Table Global Human DNA Vaccines Market Size by Application (2014-2019) (Million US$)
Table Global Human DNA Vaccines Market Size Share by Application (2014-2019)
Figure Global Human DNA Vaccines Market Size Market Share by Application (2014-2019)
Figure Global Human DNA Vaccines Revenue Market Share by Application in 2018
Figure North America Human DNA Vaccines Market Size 2014-2019 (Million US$)
Table North America Key Players Human DNA Vaccines Revenue (2018-2019) (Million US$)
Table North America Key Players Human DNA Vaccines Market Share (2018-2019)
Table North America Human DNA Vaccines Market Size by Type 2014-2019 (Million US$)
Table North America Human DNA Vaccines Market Share by Type 2014-2019
Table North America Human DNA Vaccines Market Size by Application 2014-2019 (Million US$)
Table North America Human DNA Vaccines Market Share by Application 2014-2019
Figure Europe Human DNA Vaccines Market Size 2014-2019 (Million US$)
Table Europe Key Players Human DNA Vaccines Revenue (2018-2019) (Million US$)
Table Europe Key Players Human DNA Vaccines Market Share (2018-2019)
Table Europe Human DNA Vaccines Market Size by Type 2014-2019 (Million US$)
Table Europe Human DNA Vaccines Market Share by Type 2014-2019
Table Europe Human DNA Vaccines Market Size by Application 2014-2019 (Million US$)
Table Europe Human DNA Vaccines Market Share by Application 2014-2019
Figure China Human DNA Vaccines Market Size 2014-2019 (Million US$)
Table China Key Players Human DNA Vaccines Revenue (2018-2019) (Million US$)
Table China Key Players Human DNA Vaccines Market Share (2018-2019)
Table China Human DNA Vaccines Market Size by Type 2014-2019 (Million US$)
Table China Human DNA Vaccines Market Share by Type 2014-2019
Table China Human DNA Vaccines Market Size by Application 2014-2019 (Million US$)
Table China Human DNA Vaccines Market Share by Application 2014-2019
Figure Japan Human DNA Vaccines Market Size 2014-2019 (Million US$)
Table Japan Key Players Human DNA Vaccines Revenue (2018-2019) (Million US$)
Table Japan Key Players Human DNA Vaccines Market Share (2018-2019)
Table Japan Human DNA Vaccines Market Size by Type 2014-2019 (Million US$)
Table Japan Human DNA Vaccines Market Share by Type 2014-2019
Table Japan Human DNA Vaccines Market Size by Application 2014-2019 (Million US$)
Table Japan Human DNA Vaccines Market Share by Application 2014-2019
Figure Southeast Asia Human DNA Vaccines Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Human DNA Vaccines Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Human DNA Vaccines Market Share (2018-2019)
Table Southeast Asia Human DNA Vaccines Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Human DNA Vaccines Market Share by Type 2014-2019
Table Southeast Asia Human DNA Vaccines Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Human DNA Vaccines Market Share by Application 2014-2019
Figure India Human DNA Vaccines Market Size 2014-2019 (Million US$)
Table India Key Players Human DNA Vaccines Revenue (2018-2019) (Million US$)
Table India Key Players Human DNA Vaccines Market Share (2018-2019)
Table India Human DNA Vaccines Market Size by Type 2014-2019 (Million US$)
Table India Human DNA Vaccines Market Share by Type 2014-2019
Table India Human DNA Vaccines Market Size by Application 2014-2019 (Million US$)
Table India Human DNA Vaccines Market Share by Application 2014-2019
Figure Central & South America Human DNA Vaccines Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Human DNA Vaccines Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Human DNA Vaccines Market Share (2018-2019)
Table Central & South America Human DNA Vaccines Market Size by Type 2014-2019 (Million US$)
Table Central & South America Human DNA Vaccines Market Share by Type 2014-2019
Table Central & South America Human DNA Vaccines Market Size by Application 2014-2019 (Million US$)
Table Central & South America Human DNA Vaccines Market Share by Application 2014-2019
Table Merck Company Details
Table Merck Revenue in Human DNA Vaccines Business 2014-2019 (Million US$)
Figure Merck Revenue Growth Rate in Human DNA Vaccines Business (2014-2019)
Table Merck Recent Development
Table GSK Company Details
Table GSK Revenue in Human DNA Vaccines Business 2014-2019 (Million US$)
Figure GSK Revenue Growth Rate in Human DNA Vaccines Business (2014-2019)
Table GSK Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Human DNA Vaccines Business 2014-2019 (Million US$)
Figure Sanofi Revenue Growth Rate in Human DNA Vaccines Business (2014-2019)
Table Sanofi Recent Development
Table Zoties Company Details
Table Zoties Revenue in Human DNA Vaccines Business 2014-2019 (Million US$)
Figure Zoties Revenue Growth Rate in Human DNA Vaccines Business (2014-2019)
Table Zoties Recent Development
Table Elanco Company Details
Table Elanco Revenue in Human DNA Vaccines Business 2014-2019 (Million US$)
Figure Elanco Revenue Growth Rate in Human DNA Vaccines Business (2014-2019)
Table Elanco Recent Development
Table Boehringer-Ingelheim Company Details
Table Boehringer-Ingelheim Revenue in Human DNA Vaccines Business 2014-2019 (Million US$)
Figure Boehringer-Ingelheim Revenue Growth Rate in Human DNA Vaccines Business (2014-2019)
Table Boehringer-Ingelheim Recent Development
Table Indian Immunologicals Company Details
Table Indian Immunologicals Revenue in Human DNA Vaccines Business 2014-2019 (Million US$)
Figure Indian Immunologicals Revenue Growth Rate in Human DNA Vaccines Business (2014-2019)
Table Indian Immunologicals Recent Development
Table Plumbline Life Sciences Company Details
Table Plumbline Life Sciences Revenue in Human DNA Vaccines Business 2014-2019 (Million US$)
Figure Plumbline Life Sciences Revenue Growth Rate in Human DNA Vaccines Business (2014-2019)
Table Plumbline Life Sciences Recent Development
Table Global Human DNA Vaccines Market Size by Regions (Million US$) 2019-2025
Figure Global Human DNA Vaccines Market Size Share by Regions (2019-2025)
Figure Global Human DNA Vaccines Market Size Share by Regions in 2025
Figure North America Human DNA Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Europe Human DNA Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure China Human DNA Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Japan Human DNA Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Human DNA Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure India Human DNA Vaccines Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Human DNA Vaccines Market Size Forecast (2019-2025)(Million USD)
Table Global Human DNA Vaccines Market Size by Product (2019-2025) (Million US$)
Figure Global Human DNA Vaccines Market Size by Product (2019-2025)
Figure Global Human DNA Vaccines Market Size by Product in 2025
Table Global Human DNA Vaccines Market Size by Application (2019-2025) (Million US$)
Figure Global Human DNA Vaccines Market Size by Application (2019-2025)
Figure Global Human DNA Vaccines Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Merck、GSK、Sanofi、Zoties、Elanco、Boehringer-Ingelheim、Indian Immunologicals、Plumbline Life Sciences

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ヒトDNAワクチンの世界市場：規模・現状・予測(Global Human DNA Vaccines Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp